Cytokinetics closes in on innovative heart drug
With 20 years of research and development and $1 billion in investment, top officials at South San Francisco biotech company Cytokinetics think a medicine to address heart failure…
With 20 years of research and development and $1 billion in investment, top officials at South San Francisco biotech company Cytokinetics think a medicine to address heart failure…